Geneticallypredicted exposure | Outcome | MR method | Withtrimmedgenetic instrument | With total SNPs | ||||
---|---|---|---|---|---|---|---|---|
beta | Standard error | P | beta | Standard error | P | |||
eGFRcrea | Severe COVID-19 | Inverse variance weighted | 1.01 | 0.349 | 0.004 | 0.831 | 0.296 | 0.005 |
 |  | MR-Egger | 1.28 | 0.806 | 0.114 | 1.09 | 0.66 | 0.101 |
 |  | Panelized weighted median | 1.38 | 0.557 | 0.013 | 0.615 | 0.491 | 0.21 |
 |  | MR-PRESSO | 1.01 | 0.349 | 0.004 | 0.831 | 0.296 | 0.005 |
Severe COVID-19 | eGFRcrea | Inverse variance weighted | -0.0002 | 0.001 | 0.733 | -0.0001 | 0.0006 | 0.963 |
 |  | MR-Egger | -0.0003 | 0.001 | 0.814 | -0.0002 | 0.001 | 0.887 |
 |  | Panelized weighted median | -0.0001 | 0.001 | 0.858 | 0.0003 | 0.001 | 0.626 |
 |  | MR-PRESSO | -0.0002 | 0.001 | 0.736 | -0.0001 | 0.0006 | 0.963 |
Severe COVID-19 | CKD | Inverse variance weighted | 0.015 | 0.015 | 0.318 | 0.019 | 0.014 | 0.188 |
 |  | MR-Egger | 0.02 | 0.027 | 0.458 | 0.020 | 0.027 | 0.468 |
 |  | Panelized Weighted median | -0.01 | 0.02 | 0.633 | 0.010 | 0.020 | 0.620 |
 |  | MR-PRESSO | 0.015 | 0.015 | 0.325 | 0.019 | 0.014 | 0.196 |